Friday, April 26, 2024
Outlook.com
Outlook India
Outlook Business

Venture Capital Financing

The company is laying the groundwork for its global expansion through partnerships and strategic alliances for its flagship product, Eyecyte-RPE, an experimental treatment for Dry Age-Related Macular Degeneration